FDA Further Limits Johnson & Johnson Covid Vaccine

FDA Further Limits Johnson & Johnson Covid Vaccine

Johnson & & Johnson was eclipsed long earlier by Pfizer and Moderna in the country’s vaccination project; federal officials have stated the mRNA vaccines produced by those business are both much safer and more efficient. In a statement, Johnson & & Johnson stated the F.D.A.’s action showed the already-known risk of the side result, not new information on the rate at which it occurs. The number of deaths associated to the disorder triggered by the Johnson & & Johnson’s vaccine does not appear to have increased much, if at all. About 17 million Americans have actually now gotten one dosage of Johnson & & Johnson’s vaccine, and another 1.5 million have gotten a booster dose, according to the C.D.C.’s information.

Johnson & & Johnson was eclipsed long earlier by Pfizer and Moderna in the nation’s vaccination campaign; federal officials have said the mRNA vaccines produced by those companies are both more secure and more efficient. The number of deaths attributed to the condition triggered by the Johnson & & Johnson’s vaccine does not appear to have risen much, if at all. About 17 million Americans have actually now gotten one dosage of Johnson & & Johnson’s vaccine, and another 1.5 million have gotten a booster dosage, according to the C.D.C.’s data.

Leave a Reply

Your email address will not be published. Required fields are marked *


*